- Investing Ideas
- /
- U.S. Healthcare Large Cap High Growth Potential
U.S. Healthcare Large Cap High Growth Potential
Results
10
0 new
Large Cap Companies that analysts expect to have high earnings, revenue or cash flow growth in the next 3 years.
10 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
PEN | US$266.97 | -2.6% | 5.9% | US$10.3b | US$267.44 | PE296.6x | E35.7% | n/a | ||
DXCM | US$86.83 | -2.2% | -28.2% | US$34.2b | US$96.26 | PE49.8x | E16.1% | n/a | ||
BAX | US$32.56 | 0.3% | -16.5% | US$16.9b | US$40.08 | PE137.4x | E40.5% | 2.1% | ||
MCK | US$594.75 | 0.5% | 17.9% | US$76.7b | US$650.81 | PE29.8x | E14.9% | 0.5% | ||
GMED | US$92.72 | -0.1% | 78.9% | US$12.7b | US$97.85 | PE138x | E49.1% | n/a | ||
DOCS | US$59.10 | 4.5% | 115.0% | US$11.0b | US$55.59 | PE63.4x | E8.2% | n/a | ||
LH | US$249.80 | 1.5% | 12.8% | US$21.0b | US$260.95 | PE48x | E22.4% | 1.2% | ||
BSX | US$102.36 | 0.4% | 59.0% | US$151.9b | US$102.71 | PE84.1x | E18.9% | n/a | ||
UNH | US$542.49 | 1.9% | 6.3% | US$502.1b | US$637.24 | PE34.7x | E18.7% | 1.5% | ||
MOH | US$310.41 | 2.0% | -12.5% | US$17.9b | US$357.67 | PE15.5x | E13.5% | n/a |
Page 1 of 1